# Immunoparalysis After Pancreaticoduodenectomy

> **NCT07144917** · — · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 100 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma (mPDAC)
- Pancreatic Head Tumour
- Pancreatic Fistula

## Interventions

- **DIAGNOSTIC_TEST:** mHLA-DR analysis

## Key facts

- **NCT ID:** NCT07144917
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-18
- **Primary completion:** 2027-03-18
- **Final completion:** 2027-06-18
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144917, "Immunoparalysis After Pancreaticoduodenectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07144917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*